|1.||Reddy, L Harivardhan: 1 article (09/2009)|
|2.||Arias, José L: 1 article (09/2009)|
|3.||Couvreur, Patrick: 1 article (09/2009)|
09/01/2009 - "Following intravenous administration into the mice bearing L1210 wt subcutaneous tumor, the GPOCA nanoparticles displayed significantly greater anticancer activity compared to free gemcitabine; this has been additionally confirmed by histology and immunohistochemistry studies, suggesting the potential of GPOCA for the efficient treatment of cancer."
09/01/2009 - "The cytotoxicity studies performed on L1210 tumor cells revealed a similar anticancer activity of the gemcitabine-loaded POCA (GPOCA) nanoparticle as free gemcitabine. "
|2.||ethyl 2- (5- (4- chlorophenyl)pentyl)oxiran- 2- carboxylate (POCA)